The unplanned use of sirolimus-eluting and paclitaxel-eluting stents in the same vessel is apparently safe

被引:0
|
作者
Corbett, S.
Cosgrave, J.
Babic, R.
Melzi, G.
Airoldi, F.
Carlino, M.
Montorfano, M.
Colombo, A.
机构
[1] Emo Ctr Cuore Columbus, Milan, Italy
[2] Hosp San Raffaele, I-20132 Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:648 / 648
页数:1
相关论文
共 50 条
  • [21] Paclitaxel-eluting stents for in-stent restenosis of sirolimus-eluting stents: 12 month outcomes
    Lee, Steve S.
    Wong, Garrett B.
    Price, Matthew J.
    Gollapudi, Raghava R.
    Valencia, Rafael
    Sawhney, Neil
    Schatz, Richard A.
    Teirstein, Paul S.
    CIRCULATION, 2006, 114 (18) : 644 - 644
  • [22] Paclitaxel-eluting stents for in-stent restenosis of sirolimus-eluting stents: 12 month outcomes
    Levis, Justin P.
    Lee, Steve
    Stinis, Curtis T.
    Price, Matthew J.
    Gollapudi, Raghava R.
    Valencia, Raphael
    Wong, Garrett B.
    Schatz, Richard A.
    Teirstein, Paul S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 18B - 18B
  • [23] Sirolimus-eluting and paclitaxel-eluting stents in patients with diabetes: two-year outcomes
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (4): : 178 - 178
  • [24] Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions
    Chen, Shaoliang
    Zhang, Junjie
    Ye, Fei
    Zhu, Zhongsheng
    Lin, Song
    Tian, Nailiang
    Liu, Zhizhong
    Fang, Weiyi
    Chen, Yundai
    Sun, Xuewen
    Kwan, Tak W.
    ANGIOLOGY, 2008, 59 (04) : 475 - 483
  • [25] Large long-term studies of sirolimus-eluting and paclitaxel-eluting stents are inconclusive
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (7): : 348 - 349
  • [26] Decreased late luminal loss associated with sirolimus-eluting versus paclitaxel-eluting stents
    Carol Lovegrove
    Nature Clinical Practice Endocrinology & Metabolism, 2005, 1 (2): : 65 - 66
  • [27] A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
    Hang Ouyang
    Xuehui Zeng
    Chunlei Zhang
    Linli Song
    Jiarui Xu
    Zhihui Hou
    Siya Xie
    Zheng Tao
    Jincai He
    Journal of Cardiothoracic Surgery, 16
  • [28] A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
    Ouyang, Hang
    Zeng, Xuehui
    Zhang, Chunlei
    Song, Linli
    Xu, Jiarui
    Hou, Zhihui
    Xie, Siya
    Tao, Zheng
    He, Jincai
    JOURNAL OF CARDIOTHORACIC SURGERY, 2021, 16 (01)
  • [29] Sirolimus-eluting stents versus paclitaxel-eluting stents for coronary intervention in patients with renal failure on hemodialysis
    Tsujita H.
    Hamazaki Y.
    Nishikura T.
    Yokota H.
    Kondo S.
    Hosokawa S.
    Tsukamoto S.
    Mutou M.
    Sakurai M.
    Nishimura H.
    Kobayashi Y.
    Cardiovascular Intervention and Therapeutics, 2013, 28 (1) : 9 - 15
  • [30] DIFFERENT TIME COURSE OF NEOATHEROSCLEROSIS DEVELOPMENT IN BARE METAL STENTS, SIROLIMUS-ELUTING STENTS AND PACLITAXEL-ELUTING STENTS
    Hariki, Hirotoshi
    Shinke, Toshiro
    Otake, Hiromasa
    Nakagawa, Masayuki
    Inoue, Takumi
    Osue, Tsuyoshi
    Taniguchi, Yu
    Iwasaki, Masamichi
    Nishio, Ryo
    Noritoshi, Hiranuma
    Kinutani, Hiroto
    Konishi, Akihide
    Hirata, Ken-ichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1673 - E1673